Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

57 articles from the last 90 days matching "Parkinson Disease"

ResearchRSSMay 8

MJFF renames study Parkinson’s Precision Medicine Initiative

The Michael J. Fox Foundation renamed its large Parkinson's disease study from the Parkinson's Progression Markers Initiative to the Parkinson's Precision Medicine Initiative. This name change shows how the study has evolved to focus on personalized medicine approaches. The study tracks Parkinson's patients over time to better understand the disease and find treatments tailored to individual patients.

WHY IT MATTERSIf you have Parkinson's disease, this study's shift toward precision medicine means researchers are working to identify which treatments will work best for your specific type of Parkinson's based on your individual characteristics.
Good to knowParkinson's disease
NewsRSSMay 7

Parkinson’s and menopause

Women with Parkinson's disease may experience worsening symptoms during menopause because of dropping estrogen levels. Symptoms like shaking, tiredness, and periods when Parkinson's medications stop working can get worse during this time. Managing both conditions together requires doctors from different specialties to work together and adjust treatment plans.

WHY IT MATTERSWomen with Parkinson's disease need to know that menopause can significantly worsen their motor symptoms and medication effectiveness — understanding this connection allows them to work with their doctors to adjust treatment timing and hormone considerations.
💬 Ask your doctorParkinson's disease
NewsRSSMay 7

How self-efficacy helps one man navigate life with Parkinson’s disease

Steve Yellen, a man from Connecticut, was diagnosed with Parkinson's disease seven years ago after noticing a tremor in his left hand. Instead of giving up, he decided to actively fight the disease by using problem-solving skills and determination. His story shows how a positive mindset and taking action can help people manage life with Parkinson's disease.

WHY IT MATTERSThis story demonstrates practical strategies for maintaining quality of life and mental resilience after a Parkinson's diagnosis, which can help newly diagnosed patients understand that active engagement with their condition may improve outcomes.
Good to knowParkinson's disease
ResearchRSSMay 7

Prebiotics balance gut bacteria and show results in Parkinson’s blood

Researchers found that a special type of food supplement called a prebiotic can help restore healthy bacteria in the guts of people with Parkinson's disease. Even better, they discovered a simple blood test that can measure tiny particles to show whether the treatment is working. This blood test tracks signals that travel between the gut and the brain.

WHY IT MATTERSFor Parkinson's patients, this offers a non-invasive way to monitor whether gut-targeted treatments are actually working, potentially opening a new avenue for managing symptoms through gut health.
💬 Ask your doctorParkinson's disease
ResearchBIORXIVMay 7

Preprint: WDR44 drives de novo α-synuclein aggregation at the lysosomal membrane and promotes neuronal dysfunction in Parkinson's Disease

Scientists discovered that a protein called WDR44 helps trigger the clumping of another protein called alpha-synuclein inside brain cells, specifically at structures called lysosomes (which are like the cell's trash cans). This clumping is what causes Parkinson's disease. By watching this process happen in real-time in living neurons, researchers got a clearer picture of how the disease starts.

WHY IT MATTERSUnderstanding exactly where and how alpha-synuclein clumping begins could lead to new Parkinson's treatments that stop the process at its earliest stage, potentially slowing or preventing neuronal damage before symptoms appear.
Good to knowParkinson's DiseaseSynucleinopathies
NewsRSSMay 6

Loving my uncle meant learning a new way to talk about Parkinson’s

A caregiver shares their experience learning how to talk with their uncle about his Parkinson's disease as it got worse. One difficult conversation was about needing a walker to help with movement and balance. The article focuses on how caregivers can find the right words to have these important conversations with loved ones.

WHY IT MATTERSCaregivers of people with Parkinson's disease often struggle with how to discuss mobility aids and increasing support needs—this article offers perspective on navigating those sensitive conversations.
Good to knowParkinson's disease
ResearchRSSMay 6

Genetic factors may hinder treatment in Parkinson’s caused by gene: Case

A woman with early-onset Parkinson's disease caused by a VPS13C gene mutation initially improved with medication and deep brain stimulation surgery, but then got much worse over time. Her motor symptoms (movement problems) and nonmotor symptoms (like mood or sleep issues) worsened rapidly, eventually making it impossible for her to live on her own. This case suggests that genetic causes of Parkinson's disease may affect how well standard treatments work.

WHY IT MATTERSIf you have VPS13C-related Parkinson's disease, this case shows that standard treatments like deep brain stimulation may not work as well long-term, so you should discuss genetic testing and personalized treatment plans with your neurologist.
💬 Ask your doctorParkinson's diseaseVPS13C-associated Parkinson's disease
ResearchRSSMay 5

Fruit flies help identify genes that may be treatment targets in Parkinson’s

Scientists used fruit flies to study Parkinson's disease and found three genes that might be important for treating it. When researchers changed these genes in fruit flies, the flies moved better. This discovery could help doctors develop new treatments for Parkinson's disease in the future.

WHY IT MATTERSIf these genes prove to be valid targets in human clinical trials, they could lead to new Parkinson's treatments that address movement problems through a different biological pathway than current medications.
Good to knowParkinson's disease
AdvocacyRSSMay 4

MJFF raises almost $2M in NYC Parkinson’s Unity Walk

The Michael J. Fox Foundation held a 1.2-mile walk in Central Park on April 25, 2026, where over 3,000 people participated to raise money for Parkinson's disease research. The event raised almost $2 million, and an anonymous donor is matching donations dollar-for-dollar up to $1.4 million through the end of May. This fundraising will support research efforts to find better treatments and a cure for Parkinson's disease.

WHY IT MATTERSFunds raised from this walk directly support Parkinson's research initiatives that aim to develop new treatments and accelerate progress toward a cure for patients living with this progressive neurological condition.
Good to knowParkinson's disease
NewsRSSMay 4

Getting sick when you already have a chronic illness

A columnist with Parkinson's disease shares their experience of getting the flu while managing their chronic illness. The article discusses how having the flu on top of an existing condition like Parkinson's can be especially challenging and difficult to manage.

WHY IT MATTERSPeople with Parkinson's disease need to understand that acute illnesses like the flu can complicate their existing condition and may require special attention to their care plan.
Good to knowParkinson's disease
ResearchRSSMay 1

Study finds probiotic no better than placebo for Parkinson’s anxiety

Researchers tested whether a probiotic supplement could help reduce anxiety in people with Parkinson's disease. The supplement did not work better than a placebo (a fake pill) for anxiety. However, people who took the supplement did show some improvement in thinking and memory tests, though researchers said this result needs more study before drawing conclusions.

WHY IT MATTERSIf probiotics could help with cognitive symptoms in Parkinson's disease, it might offer a simple, accessible option alongside standard treatments—but this trial suggests anxiety relief isn't one of those benefits.
💬 Ask your doctorParkinson's disease
GrantRSSApr 30

MJFF and ASAP invest $261M in global network for Parkinson’s research

Two major Parkinson's disease research organizations are giving $261 million to fund 32 new research teams around the world. This money will help scientists better understand what causes Parkinson's disease and develop treatments tailored to individual patients instead of one-size-fits-all approaches.

WHY IT MATTERSThis funding expansion means more research teams globally are working on personalized Parkinson's treatments, which could lead to therapies that work better for your specific type of disease rather than generic treatments.
Good to knowParkinson's disease
AdvocacyRSSApr 29

It’s time to ban paraquat, an herbicide linked to increased Parkinson’s risk

A landscaper is calling for a ban on paraquat, an herbicide commonly used in agriculture and landscaping. Scientific research has found that exposure to paraquat increases the risk of developing Parkinson's disease, a neurological condition that affects movement and coordination. The article argues that paraquat should be prohibited to protect workers and the public from this health risk.

WHY IT MATTERSPeople with occupational or environmental exposure to paraquat—including farmworkers, landscapers, and those living near agricultural areas—now have evidence that this chemical significantly increases their Parkinson's disease risk, making exposure reduction a critical health priority.
💬 Ask your doctorParkinson's disease
ResearchRSSApr 29

Gut protein misfolding may spot Parkinson’s years before symptoms

Researchers found that simple gut biopsies might detect signs of Parkinson's disease years before a person develops movement problems or other symptoms. They discovered that more than half of people with digestive issues but no diagnosed neurological disease showed protein misfolding in their gut tissue. This could allow doctors to identify people at high risk for Parkinson's much earlier than currently possible.

WHY IT MATTERSIf validated, routine gut biopsies could identify Parkinson's disease risk years before symptoms appear, potentially allowing earlier intervention when treatments might be most effective.
Good to knowParkinson's disease
AdvocacyRSSApr 29

Avoiding Parkinson’s care partner burnout

Taking care of someone with Parkinson's disease can be exhausting and stressful over time. Caregivers may experience burnout from the daily work and emotional weight of their role. The article suggests that recognizing early warning signs of burnout and building healthy self-care habits can help caregivers stay well while still supporting their loved one.

WHY IT MATTERSCaregiver burnout directly impacts the quality of care patients receive and their own health outcomes, making caregiver wellness essential to Parkinson's disease management.
Good to knowParkinson's disease
NewsRSSApr 29

Caregiving is also about bringing back some of what Parkinson’s takes away

This article shares a personal story about the author's uncle who had Parkinson's disease and was known for his skill at grilling and cooking. The piece explores how caregiving for someone with Parkinson's involves helping them maintain activities and hobbies they love, even as the disease takes away their abilities. It highlights the importance of preserving quality of life and meaningful experiences for people living with Parkinson's.

WHY IT MATTERSFor Parkinson's caregivers, this article emphasizes that supporting a loved one means actively helping them continue doing the things that bring them joy and define who they are, not just managing medical symptoms.
Good to knowParkinson's disease
NewsRSSApr 28

I wish I could take my husband’s pain away

A caregiver shares their personal experience of supporting a spouse living with Parkinson's disease. The article focuses on the emotional challenges of balancing work and caregiving responsibilities, and finding small moments of joy and connection despite the difficulties of managing a chronic illness.

WHY IT MATTERSCaregiver perspectives highlight the emotional and practical burden of supporting someone with Parkinson's disease, which can help other families feel less alone and understand that finding moments of normalcy and laughter is an important part of coping.
Good to knowParkinson's disease
ResearchRSSApr 28

Toxic protein clumps damage brain blood vessels in Parkinson’s: Study

Scientists discovered that in Parkinson's disease, clumps of a toxic protein called alpha-synuclein damage not just brain cells but also the tiny blood vessels that supply the brain. These two types of damage likely work together to make the disease worse over time. This finding helps explain why Parkinson's affects the brain in multiple ways.

WHY IT MATTERSUnderstanding that blood vessel damage contributes to Parkinson's progression could lead to new treatments that protect blood vessels, potentially slowing disease advancement beyond current approaches that only target brain cell damage.
Good to knowParkinson's disease
ResearchRSSApr 27

Support concerns lead women with Parkinson’s to shun DBS: Study

A new study found that women with Parkinson's disease are much less likely than men to choose a brain surgery called deep brain stimulation (DBS). The main reason is that women often worry about being a burden on their family and don't have as much support available to help them through the procedure and recovery.

WHY IT MATTERSIf you're a woman with Parkinson's considering DBS, understanding that support concerns are common may help you have more honest conversations with your doctor and family about what you actually need to move forward with treatment.
💬 Ask your doctorParkinson's disease
NewsRSSApr 27

Pill fatigue and the challenges of Parkinson’s medications

People taking Parkinson's medications often struggle with 'pill fatigue'—the burden of taking many pills throughout the day. A psychologist explains how this challenge affects patients and shares strategies to help manage medications more easily and stick with treatment plans.

WHY IT MATTERSParkinson's patients taking multiple medications daily may skip doses or stop treatment due to pill burden, which can worsen symptoms—understanding this challenge helps patients and doctors work together on solutions.
💬 Ask your doctorParkinson's disease
← PreviousPage 2 of 3Next →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases